F Whitehouse, DF Kruger, M Fineman, L Shen, JA … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Treatment with pramlintide led to a mean reduction in HbA 1c of 0.67% from baseline to
week 13 that was significantly (P < 0.0001) greater than the placebo reduction (0.16%), and a
significant placebo-corrected ... Cited by 136 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org PA Hollander, P Levy, MS Fineman, DG Maggs, LZ … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Treatment with pramlintide 120 μg BID led to a sustained reduction from baseline in HbA
1c (−0.68 and −0.62% at weeks 26 and 52, respectively), which was significantly greater than
that seen with placebo (P < 0.05). ... Cited by 168 - Related articles - BL Direct - All 5 versions
RE Ratner, R Dickey, M Fineman, DG Maggs, … - Diabetic …, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ... Cited by 111 - Related articles - BL Direct - All 5 versions
M Fineman, C Weyer, DG Maggs, S Strobel, … - Hormone and …, 2002 - thieme-connect.com Aims: Amylin is a second beta-cell hormone that is normally co-secreted with insulin in response to
meals; it complements the effects of insulin in postprandial glucose control, in part by suppressing
glucagon secretion. In patients ... Cited by 92 - Related articles - BL Direct - All 10 versions
- ►diabetesjournals.org C Weyer, A Gottlieb, DD Kim, K Lutz, S Schwartz, M … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In this randomized, single-blind, placebo-controlled, five-way
crossover study, 19 subjects with type 1 diabetes using regular insulin and 21 subjects with type 1
diabetes using insulin lispro ... Cited by 58 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org C Levetan, LL Want, C Weyer, SA Strobel, J Crean, … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In this study, 18 patients (16 of whom could be evaluated) with type 1
diabetes (age 44 ± 11 years, HbA 1c 8.2 ± 1.3% [mean ± SD]) were given mealtime injections of 30
μg pramlintide tid for 4 weeks in ... Cited by 69 - Related articles - BL Direct - All 6 versions
MF Kong, TA Stubbs, P King, IA Macdonald, JE … - Diabetologia, 1998 - Springer Gastric emptying is a significant determinant of the blood glucose response after an oral
carbohydrate load [1] due to the key role this process plays in regu- lating the rate of nutrient
delivery to the small intes- tine. ... Cited by 58 - Related articles - BL Direct - All 3 versions
B Nyholm, L Orskov, KY Hove, CH Gravholt, N … - Metabolism: clinical …, 1999 - ncbi.nlm.nih.gov To explore further the effects of the human amylin analog pramlintide on overall glycemic control
and postprandial responses of circulating glucose, glucagon, and metabolic intermediates in type 1
diabetes mellitus, 14 male type 1 ... Cited by 54 - Related articles - BL Direct - All 6 versions
C Weyer, DG Maggs, AA Young, OG … - Current pharmaceutical …, 2001 - ingentaconnect.com Abstract: Destruction and dysfunction of pancreatic beta-cells, resulting in absolute and relative
insulin deficiency, represent key abnormalities in the pathogenesis of type 1 and type 2 diabetes,
respectively. Following the ... Cited by 75 - Related articles - BL Direct - All 3 versions
